Family Medicine Research

Many of the physicians in the Department of Family Medicine are involved in innovative research and demonstration projects. Learn more about our work.

Current research highlights

Transforming Clinical Practices Initiative

Rush University Medical Center is part of a network of Midwestern hospitals awarded $46.4 million in federal funds to help physicians accelerate the shift to healthcare delivery that improves outcomes and lowers costs. The Great Lakes Practice Transformation Network is one of 29 organizations to receive funding as part of the Centers for Medicare and Medicaid Services’ $685 million Transforming Clinical Practices Initiative that provides clinicians technical assistance and peer-level support to collaborate on cost reduction and quality improvement strategies.

Principal investigator:

Michael A. Hanak, MD
Assistant Professor

The Multi-Clinic Action Trial to Control Hyperglycemia and Hypertension (MATCH2)

The MATCH2 study builds on the results of our earlier MATCH randomized controlled trial, which tested the impact of behavioral self-management coaching delivered in participants’ homes by community health workers over a two-year period in a community setting. The MATCH trial demonstrated that this intervention could improve glycemic control over a two-year period among Mexican Americans.

The purpose of the MATCH2 study is to adapt and optimize the MATCH community health worker behavioral intervention for implementation in clinic settings. Funded by the National Institutes of Health (NIH), this study will first use qualitative methods to refine the MATCH intervention to work with multi-racial, multi-ethnic clinic populations and then test that refined intervention to determine effectiveness in simultaneously improving levels of both hemoglobin A1c and blood pressure when compared to an attention control. This community-engaged study will also seek to better understand the mechanisms of community health worker effectiveness, and to determine if benefits can be maintained over time in a general clinic population.

Principal investigator:

Steven K. Rothschild, MD
Associate Professor

BRIGHTEN-Heart trial

The BRIGHTEN-Heart trial is a randomized control trial testing whether a virtual interprofessional team can improve depression outcomes in older minority adults (African Americans and Latinos, age 60 and over) with comorbid metabolic syndrome and depression. Plans are currently underway to test the BRIGHTEN methodology for primary care patients with three or more chronic conditions.

Principal investigators:

Steven K. Rothschild, MD
Associate Professor

Erin E. Emery, PhD
Assistant Professor

Past research highlights

Block-by-Block: the Humboldt Park Campaign Against Diabetes

Block-by-Block was a community-based participatory research that developed and evaluated an approach to reducing diabetes health outcomes disparities in a medically underserved inner-city community using Diabetes Block Captains. Learn more about this NIH-funded study in this news release from Rush.

Principal Investigators:

Steven K. Rothschild, MD
Associate Professor

Jose Lopez
Director
Humboldt Park Puerto Rican Cultural Center

SELECT: The Selenium and Vitamin E Cancer Prevention Trial

Rush participated in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), a National Cancer Institute-sponsored, international, multicenter randomized trial that evaluated the roles of vitamin E and selenium supplementation in reducing the risk of prostate cancer in men age 51 and older.

Site director at Rush:

Steven K. Rothschild, MD
Associate Professor